A 78-year-old man presents with an anterior ST-elevation myocardial infarction at a hospital where primary percutaneous coronary intervention cannot be delivered within the recommended time. After aspirin, fibrinolysis is given and there is no history of intracranial haemorrhage, active bleeding or anticoagulant use. Which one of the following additional antiplatelet regimens is most appropriate?